학술논문
Testing for BRAF fusions in patients with advanced BRAF/NRAS/KIT wild-type melanomas permits to identify patients who could benefit of anti-MEK targeted therapy
Document Type
Article
Author
Source
In: Journal of Clinical Pathology . (Journal of Clinical Pathology, 1 February 2020, 73(2):116-119)
Subject
Language
English
ISSN
14724146
00219746
00219746